These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8362885)

  • 1. An outpatient pharmacy services benefit in a reformed health care system. Coalition for Consumer Access to Pharmaceutical Care.
    Am J Hosp Pharm; 1993 Jul; 50(7):1464-6. PubMed ID: 8362885
    [No Abstract]   [Full Text] [Related]  

  • 2. Bridging the gap: state and private industry response to the lack of a Medicare outpatient prescription drug benefit.
    Goldstein WC; Peterson KA
    Manag Care Interface; 2002 Jun; 15(6):55-8. PubMed ID: 12087608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy benefits management and ambulatory pharmacy services.
    Strandberg LR
    Pharm Pract Manag Q; 1996 Jan; 15(4):19-26. PubMed ID: 10153841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease management: opportunity for pharmaceutical care?
    Woodward BW
    Hosp Pharm; 1995 Jul; 30(7):596, 599-603, 606-8. PubMed ID: 10144214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing and evaluating clinical pharmacy services in primary care. American College of Clinical Pharmacy.
    Pharmacotherapy; 1994; 14(6):743-58. PubMed ID: 7885980
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacy and Blue Cross Plans: reimbursement and support of innovative pharmacy programs.
    Touquan S
    Hosp Pharm; 1977 Jan; 12(1):22-4, 26. PubMed ID: 10305421
    [No Abstract]   [Full Text] [Related]  

  • 7. From hospital to drugstore: insurance and the shift to outpatient care.
    Danzon PM; Pauly MV
    LDI Issue Brief; 2001 Oct; 7(2):1-4. PubMed ID: 12523364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy benefit starts to reflect push for consumer-directed care.
    Berberabe T
    Manag Care; 2003 Sep; 12(9):29-32. PubMed ID: 14528670
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital pharmacies watch prescriptions as debate rages over 'off-label' drug use.
    Wagner M
    Mod Healthc; 1992 May; 22(19):62. PubMed ID: 10117635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical counseling and medication adherence monitoring: an essential component of any drug benefit program.
    Christensen DB
    Med Interface; 1996 Aug; 9(8):76-9. PubMed ID: 10159580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversification strategies for hospital pharmacies.
    Smith JE; Phillips DJ; Meyer GE
    Am J Hosp Pharm; 1984 Sep; 41(9):1788-91. PubMed ID: 6496513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Home Care Coalition. Ensuring the future.
    Irwin R; Kuntz C
    Caring; 1998 Jan; 17(1):14-6. PubMed ID: 10176758
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceutical services in a third-party system: an analysis.
    Donehew GR
    Contemp Pharm Pract; 1981; 4(4):246-52. PubMed ID: 10256900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conducting pharmacoeconomic evaluations in a hospital setting.
    Sanchez LA
    Hosp Pharm; 1995 May; 30(5):412, 415-6, 428. PubMed ID: 10142378
    [No Abstract]   [Full Text] [Related]  

  • 15. Unraveling the ramifications of recent pharmaceutical industry acquisitions by looking at the past, present and future of PBMs (pharmacy benefit management firms).
    Herzfeld JD
    Empl Benefits J; 1995 Mar; 20(1):20-3, 30. PubMed ID: 10142515
    [No Abstract]   [Full Text] [Related]  

  • 16. Third-party reimbursement for clinical pharmacy services.
    Riddiough MA
    Am J Hosp Pharm; 1978 Jan; 35(1):18, 20. PubMed ID: 623110
    [No Abstract]   [Full Text] [Related]  

  • 17. Employers and the pharmacy benefit.
    Penna P
    Manag Care Interface; 2000 Dec; 13(12):69-70. PubMed ID: 11141727
    [No Abstract]   [Full Text] [Related]  

  • 18. Working on the puzzle: health care coverage for low-wage workers.
    Trubek LG
    Health Matrix Clevel; 2002; 12(1):157-79. PubMed ID: 12013698
    [No Abstract]   [Full Text] [Related]  

  • 19. Advocacy coalitions and pharmacy policy in Denmark--solid cores with fuzzy edges.
    Larsen JB; Vrangbaek K; Traulsen JM
    Soc Sci Med; 2006 Jul; 63(1):212-24. PubMed ID: 16436310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using pharmaceutical cost analyses for decision making.
    U'Ren NA
    Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.